Participation in the Ischemic Optic Neuropathy Decompression Trial: sex, race, and age

References

• , NIH Revitalization Act of 1993. P.L. 103–43. Approved June 10,1993.
   Google Scholar
• McCarthy C. R. Historical background of clinical trials involving women and minorities. Acad Med 1994; 69: 695–8
   PubMed Web of Science ®Google Scholar
• Pinn V. W. The role of the N I H'S Office of Research on Women's Health. Acad Med 1994; 69: 698–702
   PubMed Web of Science ®Google Scholar
• Kaluzny A., Brawley O., Garson-Angert D., Shaw J., Godley P., Warnecke R., Ford L. Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the minority based Community Clinical Oncology Program. J Natl Cancer Inst 1993; 85(23)1945–50
   Google Scholar
• Freedman L. S., Simon R., Foulkes M. A., Friedman L., Geller N. L., Gordon D. J., Mowery R. Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993 - The perspectives of NIH clinical trialists. Control Clin Trials 1995; 16: 277–85
   PubMedGoogle Scholar
• Boissel J., Gueyffier F., Haugh M. Response to 'Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993 -The perspectives of NIH clinical trialists'. Control Clin Trials 1995; 16: 286–8
   Google Scholar
• Bourassa M. G. Response to 'Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993-The perspectives of NIH clinical trialists'. Control Clin Trials 1995; 16: 289
   Google Scholar
• Gore S. M. Inclusion of women and minorities in clinical trials. Control Clin Trials 1995; 16: 290–2
   Google Scholar
• Brawley O. W. Response to 'Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993 - The perspectives of N I H clinical trialists'. Control Clin Trials 1995; 16: 293–5
   Google Scholar
• Buist A. S., Greenlick M. R. Response to 'Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993 -The perspectives of NIH clinical trialists'. Control Clin Trials 1995; 16: 296–8
   Google Scholar
• Fraser W. D. Response to 'Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993 - The perspectives of N I H clinical trialists'. Control Clin Trials 1995; 16: 299
   Google Scholar
• Baldwin W. Impact of the NIH inclusion guidelines. Control Clin Trials 1995; 16: 300
   Google Scholar
• Woolson R. F., Jones M. F., Clarke W. R., Torner J. C. Discussion of 'Inclusion of women and minorities in clinical trials and the NI H Revitalization Act of 1993 - The perspectives of NIH clinical trialists'. Control Clin Trials 1995; 16: 301–3
   Google Scholar
• Meinert C. L. Comments on N I H Clinical Trials Valid Analysis Requirement. Control Clin Trials 1995; 16: 304–6
   Google Scholar
• Piantadosi S. Commentary regarding 'Inclusion of women and minorities in clinical trials and the N1 H Revitalization Act of 1993 -The perspectives of NIH clinical trialists'. Control Clin Trials 1995; 16: 307–9
   Google Scholar
• Freedman L. S., Simon R., Foulkes M. A., Friedman L., Geller N. L., Gordon D. J., Mowery R. Response to discussants' letters. Control Clin Trials 1995; 16: 310–2
   Google Scholar
• Conference on the recruitment and retention of minority participants in clinical cancer research, Washington, D.C., January, 26–271996
   Google Scholar
• Harlan W. Creating an NIH Clinical Trials Registry: A user-friendly approach to health care. JAMA 1994; 271: 1729
   Google Scholar
• The Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA 1995; 273: 625–32
   PubMed Web of Science ®Google Scholar
• Ischemic Optic Neuropathy Decompression Trial (IONDT) Research Group. Manual of Operations. University of Maryland at Baltimore, Baltimore 1992
   Google Scholar
• The Ischemic Optic Neuropathy Decompression Trial Research Group. Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol 1996; 114: 1366–74
   PubMedGoogle Scholar
• Johnson L. N., Arnold A. C. Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy. Population-based study in the state of Missouri and Los Angeles County, California. J Neuro-Ophthalmol 1994; 14: 38–44
   PubMed Web of Science ®Google Scholar
• Kalenak J., Kosmorsky G. S., Rockwood E. J. Nonarteritic anterior ischemic optic neuropathy and intraocular pressure. Arch Ophthalmol 1991; 109: 660–1
   Google Scholar
• Hayreh S. S., Joos K. M., Podhasky P. A., Long C. R. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1994; 118: 766–80
   PubMed Web of Science ®Google Scholar
• Ellenberger C., Burde R. M., Keltner J. L. Acute optic neuropathy treatment with diphenylhydantoin. Arch Ophthalmol 1974; 91: 435–8
   Google Scholar
• Rizzo J. F., Lessell S. Optic neuritis and ischemic optic neuropathy overlapping clinical profiles. Arch Ophthalmol 1991; 109: 1668–72
   PubMedGoogle Scholar
• Fry C. L., Carter J. E., Kanter M. C., Tegeler C. H., Tuley M. R. Anterior ischemic optic neuropathy is not associated with carotid artery atherosclerosis. Stroke 1993; 24: 539–42
   PubMed Web of Science ®Google Scholar
• Katz B., Spencer W. H. Hyperopia as a risk factor for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1993; 116: 754–8
   PubMedGoogle Scholar
• Sergott R. C., Cohen M. S., Bosley T. M., Savino P. J. Optic nerve decompression may improve the progressive form of nonarteritic ischemic optic neuropathy. Arch Ophthalmol 1989; 107: 1743–54
   PubMedGoogle Scholar
• Arnold A. C., Hepler R. S. Fluorescein angiography in acute nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1994; 117: 222–30
   PubMed Web of Science ®Google Scholar
• Beri M., Klugman M. R., Kohler J. A., Hayreh S. S. Anterior ischemic optic neuropathy. Ophthalmology 1987; 94: 1020–8
   PubMed Web of Science ®Google Scholar
• Borchert M., Lessell S. Progressive and recurrent nonarteritic ischemic optic neuropathy. Am J Ophthalmol 1988; 106: 443–9
   PubMed Web of Science ®Google Scholar
• Chung S. M., Gay C. A., McCrary J. A. Nonarteritic ischemic optic neuropathy. The impact of tobacco use. Ophthalmology 1994; 101: 779–82
   PubMed Web of Science ®Google Scholar
• Kelman S. E., Elman M. J. Optic nerve sheath decompression for nonarteritic ischemic optic neuropathy improves multiple visual function measurements. Arch Ophthalmol 1991; 109: 667–71
   PubMedGoogle Scholar
• Repka M. X., Savino P. J., Schatz N. J., Sergott R. C. Clinical profile and long-term implications of anterior ischemic optic neuropathy. Am J Ophthalmol 1983; 96: 478–83
   PubMed Web of Science ®Google Scholar
• Glaser J. S., Teimory M., Schatz N. J. Optic nerve sheath fenestration for progressive ischemic optic neuropathy. Arch Ophthamol 1994; 112: 1047–50
   PubMedGoogle Scholar
• Spoor T. C., McHenry J. G., Lau-Sickon L. Progressive and static nonarteritic ischemic optic neuropathy treated by optic nerve sheath decompression. Ophthalmology 1993; 100: 306–11
   PubMed Web of Science ®Google Scholar
• Spoor T. C., Wilkinson M. J., Ramocki J. M. Optic nerve sheath decompression for the treatment of progressive nonarteritic ischemic optic neuropathy. Am J Ophthalmol 1991; 724–8, in
   Google Scholar
• Ishikawa A., Muroi S. The optic disk in anterior ischemic optic neuropathy associated with retinal artery occlusion. Ophthalmologica 1990; 201: 14–8
   Google Scholar
• Johnson L. N., Kuo H. C., Arnold A. C. HLA-A29 as a potential risk factor for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1993; 115: 540–2
   PubMedGoogle Scholar
• Commission on Professional and Hospital Activities. The international classification of diseases, clinical modification, 1CD-9-CM. 9th Revision. Commission on Professional and Hospital Activities, Ann Arbor 1978
   Google Scholar
• County and City Extra Annual Metropolitan, City and County Data Book, C. Slater, G. E. Hall. Bernan Press, Lanham, Maryland 1992, 1992
   Google Scholar
• U.S. Department of Commerce. Bureau of the Census. Census of Population. General Population Characteristics West Virginia. U.S. Government Printing Office, Washington, DC 1990; 1992
   Google Scholar
• U.S. Department of Commerce. Bureau of the Census. Census of Population. General Population Characteristics United States. U.S. Government Printing Office, Washington, DC 1990; 1992
   Google Scholar
• National Eye Institute. Clinical Trials Supported by the National Eye Institute. N I H Publication No. 93 - 2910, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Washington, DC August, 1993
   Google Scholar
• Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Results of a randomized trial - D R V S Report Number 3. Ophthalmology 1988; 95: 1307–20
   PubMedGoogle Scholar
• Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 1990; 108: 816–24
   PubMedGoogle Scholar
• Prism Adaptation Study Research Group. Efficacy of prism adaptation in the surgical management of acquired esotropia. Arch Ophthalmol 1990; 108: 1248–56
   Google Scholar
• Branch Vein Occlusion Group. Branch vein occlusion. Arch Ophthalmol 1986; 104: 34–41
   Google Scholar
• Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT): 5. Subgroup differences at enrollment. Ophthalm Surg 1993; 24(4)232–40
   Google Scholar
• Diabetic Retinopathy Study Research Group. Design, methods, and baseline results, DRS Report Number 6. Invest Ophthalmol Vis Sci 1981; 21(1pt 2)1–226
   Google Scholar
• Javitt J., McBean M., Nicholson G., Ba-Bish D., Warren J., Krakauer H. Under-treatment of glaucoma among Black Americans. N Engl J Med 1991; 325: 1418–22
   PubMed Web of Science ®Google Scholar
• Glynn R. J., Gurwitz J. H., Bohn R. L., Mo-Nane M., Choodnovskiy I., Avorn J. Old age and race as determinants of initiation of glaucoma therapy. Am J Epidemiol 1993; 138: 395–406
   Google Scholar
• Martin M. J., Sommer A., Gold E. B., Diamond E. L. Race and primary open-angle glaucoma. Am J Ophthalmol 1985; 99: 383–7
   PubMed Web of Science ®Google Scholar
• Ginzberg E. Access to health care for Hispanics. JAMA 1991; 265: 238–41
   PubMed Web of Science ®Google Scholar
• Langley G. R., Sutherland H. J., Wong S., Minkin S., Llewellyn-Thomas H. A., Till J. E. Why are (or are not) patients given the option to enter clinical trials. Control Clin Trials 1987; 8: 49–59
   Google Scholar
• Taylor K. M., Margolese R. G., Soskolne C. L. Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. N Engl J Med 1984; 310: 1363–7
   PubMed Web of Science ®Google Scholar
• Millon-Underwood S., Sanders E., Davis M. Determinants of participation in state of the art cancer prevention, early detection/screening, and treatment trials among African-Americans. Cancer Nursing 1993; 16: 25–33
   PubMed Web of Science ®Google Scholar
• Boghen D. R., Glaser J. S. Ischaemic optic neuropathy. The clinical profile and natural history. Brain 1975; 98: 689–708
   PubMed Web of Science ®Google Scholar
• Freeman H. Cancer in the socioecono-mically disadvantaged. CA Cancer J Clin 1989; 39: 266–88
   PubMed Web of Science ®Google Scholar
• Eisenberg J. Sociologic influences on decision-making by clinicians. Ann Int Med 1979; 90: 957–64
   PubMed Web of Science ®Google Scholar
• Blendon R. J., Aiken L. H., Freeman H. E., Corey C. R. Access to medical care for Black and White Americans. JAMA 1989; 261: 278–81
   PubMed Web of Science ®Google Scholar
• Petchers M. K., Milligan S. E. Access to health care in a Black urban elderly population. Gerontologist 1988; 28(2)213–7
   Google Scholar
• Varma R., Tielsch J. M., Quigley H. A., Hilton S., Katz J., Spaeth G. L., Sommer A. Race-, age-, gender-, and refractive error-related differences in the normal optic disc. Arch Ophthalmol 1994; 112: 1068–76
   PubMed Web of Science ®Google Scholar
• Beck R. W., Messner D. K., Musch D. C., Martonyi C. L., Lichter P. R. Is there a racial difference in physiologic cup size. Ophthalmology 1985; 92: 873–6
   PubMed Web of Science ®Google Scholar
• Quigley H. A., Brown A. E., Morrison J. D., Drance S. M. The size and shape of the optic disc in normal human eyes. Arch Ophthalmol 1990; 108: 51–7
   PubMedGoogle Scholar
• Maisel J. M., Pearstein C. S., Adams W. H., Heotis P. M. Large optic disks in the Marshallese population. Am J Ophthalmol 1989; 107: 145–50
   Web of Science ®Google Scholar
• Johnson L. N., Krohel G. B., Allen S. D., Mozayeni R. Recurrent herpes labialis as a potential risk factor for nonarteritic anterior ischemic optic neuropathy. J Natl Med Assoc 1996; 88: 369–73
   Google Scholar
• Thomas C. R., Pinto H. A., Roach M., Vaughn C. B. Participation in clinical trials: Is it state-of-the-art treatment for African Americans and other people of color. J Natl Med Assoc 1994; 86: 177–82
   PubMed Web of Science ®Google Scholar
• Moy E. Physician race and care of minority and medically indigent patients. JAMA 1995; 273: 1515–20
   PubMed Web of Science ®Google Scholar
• Harris Y., Gorelick P. B., Samuels P., Bempong I. Why African Americans may not be participating in clinical trials. J Natl Med Assoc 1996; 88(10)630–4
   PubMed Web of Science ®Google Scholar
• Lin-Fu J. S. Population characteristics and health care needs of Asian Pacific Americans. Publ Health Rep 1988; 103(1)18–27
   PubMed Web of Science ®Google Scholar
• Stavig G. R., Igra A., Leonard A. R. Hypertension and related health issues among Asians and Pacific Islanders in California. Publ Health Rep 1988; 103(1)28–37
   Google Scholar